Distrust in generic drugs will likely dampen pharmaceutical industry

Korea's generic drug makers are likely to lose their momentum, as the Korea Food and Drug Administration revealed a series of reports on manipulated test results of generic drugs whose efficacy is not equivalent to their brand-name counterparts, according to pharmaceutical sources say.

The sources indicate that if patients continue to question the safety and efficacy of genetic drugs after g...